Streetbeat News

Revenues

RDY

Dr. Reddy's Laboratories reported fiscal Q2 earnings that missed estimates, but revenues exceeded expectations. The earnings were impacted by a one-time acquisition cost and an impairment charge on non-current assets. Global Generics revenues showed growth.

Portfolio Pulse from

November 06, 2024 | 4:15 pm

IFF

International Flavors & Fragrances (IFF) reported Q3 earnings that missed estimates, but sales increased year-over-year. The company has raised its 2024 sales guidance to $11.3-$11.4 billion, up from the previous $11.1-$11.3 billion range.

Portfolio Pulse from

November 06, 2024 | 4:15 pm

RARE

Ultragenyx reported a narrower-than-expected loss for Q3, with revenues surpassing estimates. The company saw a year-over-year increase in product sales.

Portfolio Pulse from

November 06, 2024 | 4:00 pm

LUMN

Lumen Technologies reported a narrower-than-expected loss for Q3, despite a year-over-year decline in revenues. The company's legacy business faced challenges, but growth in Quantum Fiber and increasing PCF deals show promise.

Portfolio Pulse from

November 06, 2024 | 4:00 pm

QLYS

Qualys reported strong Q3 2024 earnings, driven by revenue growth through channel partners, despite rising sales and marketing expenses. The company provided upbeat guidance, which may positively influence its stock price.

Portfolio Pulse from

November 06, 2024 | 3:45 pm

F

Ford is facing higher costs, but there is potential upside for investors in the near term.

Portfolio Pulse from

November 06, 2024 | 3:45 pm

BOX

Tritax Big Box REIT is set for growth with falling interest rates, rental income hikes, and a strategic acquisition. Despite a share price drop, it presents a buying opportunity due to expected rental income increases and a strong balance sheet.

Portfolio Pulse from

November 06, 2024 | 3:45 pm

GEN

The article discusses Gen Digital's (GEN) changing revenue from international markets and its impact on Wall Street's predictions and the stock's prospects.

Portfolio Pulse from

November 06, 2024 | 3:30 pm

OSK

Oshkosh Corporation (OSK) reported better-than-expected third-quarter results. However, the company revised its 2024 sales expectations down to $10.6 billion from $10.7 billion, leading to a 2.5% drop in its share price.

Portfolio Pulse from

November 06, 2024 | 3:30 pm

LPX

Louisiana-Pacific (LPX) reported strong Q3 earnings and net sales, surpassing estimates. The Siding business showed solid demand, while the OSB segment had weaker contributions. The company has raised its guidance.

Portfolio Pulse from

November 06, 2024 | 3:30 pm